Eastman director gifts 15,720 shares of stock
Eastman Chemical director James J. O'Brien reports multiple bona fide stock gifts, shifting some holdings into a family trust.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EASTMAN CHEMICAL CO (EMN) director James J. O'Brien reported several gift transfers of common stock on September 2, 2026. He made bona fide gifts of 5,378 shares held directly and 2,482 shares held indirectly through a revocable trust, and an associated family trust is reported as receiving 7,860 shares. After these transactions, he holds 1,628 shares directly and 7,860 shares indirectly through the O'Brien Family Dynasty Trust. No transactions are reported under a Rule 10b5-1 trading plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 5,378 | $0.00 | $0.00 |
| Gift | Common Stock | 2,482 | $0.00 | $0.00 |
| Gift | Common Stock F1 | 7,860 | $0.00 | $0.00 |
Footnotes (1)
- F1. Katherine B. O'Brien, TTEE
Key Figures
Key Terms
bona fide gift regulatory
indirect ownership financial
Revocable Trust financial
Dynasty Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did EMN director James J. O'Brien report on September 2, 2026?
Were James J. O'Brien’s EMN stock gifts made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.